Navigation Links
Australia Contributes Additional Funds for HIV Prevention in North-East

Australian High Commissioner to India, John McCarthy, has announced additional funding for HIV/AIDS and drugs prevention in Nagaland, Meghalaya, Manipur and Mizoram.

The project, "Prevention of Drugs and HIV/AIDS in India" will be implemented by the UN Office on Drugs and Crime (UNODC) with additional funding of USD 330,000, a High Commission release said.

The Australian Government has committed its aid program in India to preventing drug abuse and HIV/AIDS particularly in the North-East, said McCarthy.

The main objective of this project is to strengthen the capacity of government and civil society organisations in preventing drug abuse. This will also scale-up interventions that reduce the harmful consequences of drug use, especially HIV, he added.

The HIV/AIDS epidemic is a serious cause of concern not only in India, but across the world. With this project, Australia hopes to contribute to the efforts of organisations such as the United Nations towards preventing the epidemic, said McCarthy.

The project strategy includes engaging a community and social action to spread awareness among young people about HIV/AIDS. This includes the introduction of drug awareness programs for schools and the establishment of self-help groups for young women affected and afflicted by drug use and HIV.

The Government of Australia has supported UNODC on this project since 2005, with total Australian funding under the project being USD 854,000.

Australias previous involvement in the North-East region through HIV/AIDS initiatives include the SHALOM project (a three-year long project initiated in Manipur between 1994-97 for the prevention and control of HIV/AIDS); the India-Australia capacity building training project (a series of teaching modules on HIV/AIDS); and the Prevention of transmission of HIV among drug users in SAARC countries project (aimed at strengthening the capacities of State governments and civil society organisations to prevent the spread of HIV/AIDS amongst injecting drug users in the SAARC region).


'"/>




Related medicine news :

1. Australian Scientists Silence Cancer Gene
2. Australia earmarks $74 Million to Fight Bird Flu
3. Australian Government To Stockpile Anti-Bird Flu Drug Relenza
4. Obesity among The Poor in Australia.
5. Increase In Health Insurance Premium Likely In Australia
6. Australian Company Gets $10 million For Developing Skin Cancer Gel
7. Australian Health funds stand accused
8. Bird flu scare in Australia
9. Australia to Show Leniency towards U.S. Pharmaceutical Companies
10. Australia awaits US FDA reports on ADHD drugs
11. No booster vaccine For every fourth child in Australia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... ... enough sleep affects much more than energy – it also has mental and physical benefits. ... motor reaction time, which can increase the risk of having a car accident. , ... the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... http://www.wiredlifesolutions.com , “Computers are everywhere and they’re here to stay,” said ... Global Climate Change and Your Health on Voice America sponsored by Nature’s Tears® ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The ... board members and officers for 2017-2018. The annual board election process has been in ... a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment ... projected period The Cardiology Devices segment is likely ... US$ 15 Mn in 2018 over 2017. By the end ... market valuation close to US$ 700 Mn, expanding at a ... segment dominated the Asia Pacific reprocessed ...
Breaking Medicine Technology: